Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/139554| Title: | Monotherapy versus dual lipid lowering therapy in high risk coronary artery disease patients |
| Authors: | Spiteri, Shanice Wirth, Francesca Gauci, Marilyn Desira, Josette Abela, Mark Xuereb, Robert G. Cassar Maempel, Andrew Camilleri, Liberato Azzopardi, Lilian M. |
| Keywords: | Coronary heart disease -- Treatment Coronary heart disease -- Patients Coronary artery disease -- Treatment Antilipemic agents -- Therapeutic use Statins (Cardiovascular agents) |
| Issue Date: | 2025 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Spiteri, S., Wirth, F., Gauci, M., Desira, J., Abela, M., Xuereb, R. G.,…Azzopardi, L. M. (2025). Monotherapy versus dual lipid lowering therapy in high risk coronary artery disease patients. Poster session presented at the 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences, Copenhagen. |
| Abstract: | Introduction: European
Society of Cardiology guidelines for the management of dyslipidaemias
recommend dual therapy with a high intensity statin and ezetimibe if target
low density lipoprotein cholesterol, LDL-C 1 4 mmol/L) is not achieved with statin
monotherapy. Aim: To assess lipid lowering therapy and LDL-C levels in coronary artery disease (CAD) patients who underwent a cardiac intervention. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/139554 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Monotherapy versus dual lipid lowering therapy in high risk coronary artery disease patients 2025.pdf | 212.29 kB | Adobe PDF | View/Open | |
| Monotherapy_versus_dual_lipid-lowering_therapy_in_high-risk_coronary_artery_disease_patients_2025.pdf | 327.17 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.